Posted in | News | Business | Events

Aceto Expands GMP Product Lines for Biopharmaceutical and Vaccine Manufacturing with Acquisition of A&C Bio Buffer

Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced today its acquisition of A&C Bio Buffer Ltd, a GMP (Good Manufacturing Practices) manufacturer of custom buffer and chemical blend products used in the manufacturing of biopharmaceutical drug products.

This transaction complements Aceto’s acquisition earlier this year of A&C, a global manufacturer of GMP specialty excipients and custom process solutions, and reinforces the company’s expanded business development efforts in the biopharmaceutical sector.

“A&C Bio Buffer is a natural add-on to our acquisition of A&C and aligns with our commitments to the biopharmaceutical space,” said Gilles Cottier, Chief Executive Officer of Aceto. “It is a nimble, highly customer-centric organization serving some of the top biopharmaceutical manufacturers in Europe. Its rapid growth reflects a reputation for service and quality, which recently led to its key role in the raw material supply chain for COVID-19 vaccines. A&C Bio Buffer enhances our growing European manufacturing footprint and commercial presence.  We believe the shared lineage reflected in A&C Bio Buffer’s skills, culture and customer focus will further support our evolution as a leading supplier of critical raw materials in the life sciences sector.”

A&C Bio Buffer GMP manufactures over 50 products including biological buffers, process solutions, cleaning solutions and WFI (Water for Injection) in its state-of-the-art facility in Limerick, Ireland.  A&C Bio Buffer’s combination of advanced manufacturing capabilities, expertise, robust quality management systems, technical excellence, commitment to transparency and customer-centric approach make it a leading global GMP partner for custom buffer solutions and chemical blends.

“We are proud of A&C Bio Buffer’s outstanding reputation for quality and customer service and its emergence as a leading specialty manufacturer of GMP custom buffers and chemical blend products for the biopharmaceutical industry,” said John Godfrey, CEO of A&C Bio Buffer Ltd. “We are delighted that our unique capabilities, European footprint and custom products are being incorporated into Aceto, as we continue our evolution as a dynamic new solutions provider to the global biopharmaceutical sector.”

Aceto will continue to support A&C BioBuffer’s manufacturing facilities and offices in Ireland. Financial terms were not disclosed.

Source: https://www.aceto.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Aceto. (2021, October 14). Aceto Expands GMP Product Lines for Biopharmaceutical and Vaccine Manufacturing with Acquisition of A&C Bio Buffer. AZoM. Retrieved on November 28, 2021 from https://www.azom.com/news.aspx?newsID=56941.

  • MLA

    Aceto. "Aceto Expands GMP Product Lines for Biopharmaceutical and Vaccine Manufacturing with Acquisition of A&C Bio Buffer". AZoM. 28 November 2021. <https://www.azom.com/news.aspx?newsID=56941>.

  • Chicago

    Aceto. "Aceto Expands GMP Product Lines for Biopharmaceutical and Vaccine Manufacturing with Acquisition of A&C Bio Buffer". AZoM. https://www.azom.com/news.aspx?newsID=56941. (accessed November 28, 2021).

  • Harvard

    Aceto. 2021. Aceto Expands GMP Product Lines for Biopharmaceutical and Vaccine Manufacturing with Acquisition of A&C Bio Buffer. AZoM, viewed 28 November 2021, https://www.azom.com/news.aspx?newsID=56941.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit